日科化学(300214) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 616,082,950.91, a 50.94% increase year-on-year[9] - Net profit attributable to shareholders increased by 85.49% to CNY 40,951,085.89 compared to the same period last year[9] - Basic earnings per share reached CNY 0.10, a 100% increase compared to the same period last year[9] - Operating revenue for the current period increased by 40.35% compared to the same period last year, driven by higher product prices and increased sales volume[20] - Operating profit for the current period was ¥100,643,333.44, compared to ¥85,834,750.00 in the previous period, reflecting a growth of approximately 17.3%[49] - Net profit for the current period was ¥77,281,903.52, an increase from ¥66,538,685.79, which is a growth of around 16.5%[49] Assets and Liabilities - Total assets increased by 16.57% to CNY 1,720,716,714.70 compared to the end of the previous year[9] - The total liabilities of the company were CNY 149,435,750.99, compared to CNY 117,199,776.68 at the beginning of the year, showing an increase of about 27.5%[36] - The company's current assets totaled CNY 1,044,442,608.88, up from CNY 857,146,101.88, indicating a growth of about 22%[34] - Accounts receivable increased significantly to CNY 365,345,989.13 from CNY 273,588,070.93, marking a rise of about 33.5%[34] - Inventory levels rose to CNY 138,713,710.75 from CNY 115,463,534.93, which is an increase of approximately 20.1%[34] Cash Flow - The company reported a net cash flow from operating activities of CNY 64,238,015.24, a 100.07% increase year-on-year[9] - Cash flow from operating activities generated a net amount of ¥64,238,015.24, compared to ¥32,108,352.01 in the previous period, indicating a growth of approximately 100.5%[56] - The net cash flow from operating activities was ¥34,670,862.82, compared to a negative cash flow of ¥25,643,049.37 in the previous period, indicating a significant improvement[60] - Total cash inflow from operating activities reached ¥1,062,178,969.94, up from ¥694,263,122.91 in the same period last year, reflecting a growth of approximately 52.9%[59] Shareholder Information - The total number of shareholders at the end of the reporting period was 18,252[13] - The largest shareholder, Zhao Dongri, holds 34.58% of the shares, amounting to 147,230,382 shares[13] - The company reported a commitment to not transfer or entrust the management of shares for 36 months from the date of stock listing[27] - The company’s major shareholders, including Zhao Dongri, committed to not transferring shares exceeding 15% of their total holdings annually during their tenure[27] Financial Commitments and Compliance - The company guarantees the accuracy and completeness of its periodic reports and significant information disclosures[28] - The company has committed to not using insider information for stock trading activities[28] - The company will strictly adhere to relevant laws and regulations regarding stock issuance and management[28] - The company has committed to ensuring that any public communications do not mislead investors regarding stock price[28] Costs and Expenses - Operating costs for the current period increased by 43.96% compared to the same period last year, mainly due to rising raw material prices and increased sales volume[20] - Financial expenses increased by 3.21 times compared to the same period last year, mainly due to reduced deposit interest and increased exchange losses[20] - The company reported a significant increase in sales expenses, which rose to CNY 19,495,948.57 from CNY 17,397,412.69, reflecting an increase of 12%[43] - The company incurred financial expenses of ¥9,136,887.03, compared to a financial income of ¥4,135,462.42 in the previous period, indicating a significant shift in financial performance[49]